PMA supplement
P130022 S046: Nevro Corp Senza™ Spinal Cord Stimulation (SCS) System
FDA PMA supplement · Special (Immediate Track) · Nevro Corporation
Key facts
| Original PMA | P130022 |
|---|---|
| Supplement number | S046 |
| Supplement type | Special (Immediate Track) |
| Reason for the supplement | Labeling Change - Indications/instructions/shelf life/tradename |
| Trade name | Nevro Corp Senza™ Spinal Cord Stimulation (SCS) System |
| Generic name | Stimulator, spinal-cord, totally implanted for pain relief |
| Applicant | Nevro Corporation |
| Product code | LGW |
| Received date | Apr 15, 2022 |
| Decision date | May 13, 2022 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: